News
Health Matters: Health Canada approves Ozempic to help reduce kidney decline
Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 diabetes. The decision comes after an international clinical trial found the risk of deteriorating kidney function was 24 per cent lower in patients taking Ozempic compared to those taking a placebo injection.
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January.
It says Novo Nordisk, which markets Ozempic, is expecting a shortage in Canada of the 0.25 mg, 0.5 mg and 1 mg injection pens until early 2024.
With shortages of Ozempic at U.S. pharmacies, some Americans have been turning to Canada and Mexico to buy the medication, a Type 2 diabetes treatment many people are using off-label to lose ...
Ozempic ® demonstrated clinically meaningful improvements in blood sugar and body weight vs comparators 1 MISSISSAUGA, ON, Jan. 9, 2018 /CNW/ - Novo Nordisk announced today that Health Canada has ...
Jade Thirlwall has made the heartbreaking confession that she struggles daily to not use weight-loss drugs after trolling.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback